In 2023, GC Pharma, also known as Green Cross, posted a sales revenue of around 1.6 trillion South Korean won. This represents a slight decrease from the previous year, which was the highest sales revenue recorded since 2015.
Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2023
(in trillion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DART. (March 20, 2024). Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2023 (in trillion South Korean won) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART. "Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2023 (in trillion South Korean won)." Chart. March 20, 2024. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART. (2024). Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2023 (in trillion South Korean won). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART. "Sales Revenue of Gc Pharma (Green Cross Corporation) from 2015 to 2023 (in Trillion South Korean Won)." Statista, Statista Inc., 20 Mar 2024, https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART, Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2023 (in trillion South Korean won) Statista, https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/ (last visited December 21, 2024)
Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2023 (in trillion South Korean won) [Graph], DART, March 20, 2024. [Online]. Available: https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/